Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense is included within the condensed consolidated statements of operations and comprehensive loss as follows:


	Three months ended March 31,
	2025		2024
Cost of services	$	168	$	48
Research and development	419		(187)
Selling and marketing	546		(20)
General and administrative	2,850		(292)
Total stock-based compensation expense1,2	$	3,983	$	(451)

(1) The Company recorded an aggregate reversal of stock-based compensation of $0.6 million and $3.2 million during the three months ended March 31, 2025 and 2024, respectively, due to forfeiture activities upon employee terminations.

(2) Includes $0.3 million of expenses related to the 2021 Employee Stock Purchase Plan for the three months ended March 31, 2025.

Schedule of Stock Option Activity

The following table summarizes the stock option activity during the three months ended March 31, 2025:


	Stock Options	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Life (years)	Aggregate Intrinsic Value
Outstanding at December 31, 2024	341,280	$	44.83	5.99	$	12,429

Exercised	(33,442)	$	21.98

Outstanding at March 31, 2025	307,838	$	47.25	5.75	$	14,102
Options exercisable at March 31, 2025	267,578	$	43.79	5.53	$	12,992

Schedule of Restricted Stock Units Activity

The following table summarizes restricted stock unit activity during the three months ended March 31, 2025:


	Restricted Stock Units	Weighted-Average Grant Date-Fair Value Per Unit
Outstanding at December 31, 2024	1,869,561	$	12.03
Granted1	460,439	$	94.22
Vested	(330,350)	$	10.90
Forfeited	(202,549)	$	13.46
Outstanding at March 31, 2025	1,797,101	$	33.20

(1) Includes 73,677 PRSUs granted during the three months ended March 31, 2025 with a weighted-average grant-date fair value of $98.47.